This inventor holds 1 USPTO granted patent. Top assignee: University of Washington. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Ranae M Ranade
Introduction: Ranae M Ranade is a prominent inventor based in Seattle, Washington. With a focus on cutting-edge biotechnological solutions, Ranae has made significant strides in the field of medicinal chemistry. His contributions are especially relevant to the treatment of diseases through innovative mechanisms of action.
Latest Patents: Ranae M Ranade holds a patent for "Specific inhibitors of methionyl-tRNA synthetase." This patent involves compositions that inhibit Methionyl-tRNA synthetase (MetRS) and represents a promising approach for treating diseases that can be ameliorated by this inhibition. The research behind this patent underscores the importance of targeting specific biochemical pathways to develop effective therapeutic strategies.
Career Highlights: As an inventor affiliated with the University of Washington, Ranae has been involved in pioneering research that marries biochemistry with medical applications. His work reflects a commitment to advancing our understanding of cellular mechanisms and translating that knowledge into tangible health solutions.
Collaborations: Ranae M Ranade has collaborated with notable colleagues including Frederick Simmons Buckner and Ximena Barros Alvarez. This partnership has not only enriched his research endeavors but has also fostered a collaborative environment conducive to groundbreaking discoveries.
Conclusion: Ranae M Ranade exemplifies the spirit of innovation within the scientific community. His work on inhibitors of methionyl-tRNA synthetase represents a vital step forward in the realm of therapeutic development. With ongoing collaborations and research, Ranae continues to contribute significantly to the field of medicinal chemistry, potentially impacting the treatment of various diseases in the near future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
